Optimi Health holder YA II PN reports 7.1% stake
Optimi Health Corp. Schedule 13G reports that YA II PN, Ltd. and affiliated entities collectively beneficially own 400,000 shares of common stock, equal to 7.1% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Optimi Health Corp. Schedule 13G reports that YA II PN, Ltd. and affiliated entities collectively beneficially own 400,000 shares of common stock, equal to 7.1% of the class. The filing lists shared voting and dispositive power over 400,000 shares and identifies related entities and Mark Angelo as the decisionmaker.
The filing names YA Global Investments II (U.S.), Yorkville Advisors Global, Yorkville Advisors Global II, LLC, YAII GP, YAII GP II, LLC, SC-Sigma Global Partners and Mark Angelo as affiliates that may be deemed to beneficially own the same 400,000 shares. Signatures show the filing activity dated in May 2026.
Insights
YA II group holds a meaningful 400,000-share stake (7.1%).
The Schedule 13G lists a 400,000‑share position with shared voting and dispositive power; Mark Angelo is identified as making investment decisions for YA II. The filing treats multiple affiliated entities as part of a group.
Implications depend on whether the group increases or reduces holdings; subsequent filings would show changes in ownership or voting intent.
Group classification clarifies control links across Yorkville entities.
The disclosure describes the ownership chain and affiliate relationships among the YA entities and SC‑Sigma, indicating shared voting/dispositive arrangements for 400,000 shares. This is standard group attribution language used in beneficial ownership filings.
Monitor future filings for any change in voting intent, conversions, or additional acquisitions reported on Schedule 13D/13G amendments.
AI-generated analysis. How Rhea-AI works. Not financial advice.